Hsu, I-Ling <br/><br/>
Targeting FXYD2 by cardiac glycosides potently blocks tumor growth in ovarian clear cell carcinoma.  [electronic resource] 

 -  Oncotarget  Sep 2016 
 - 62925-62938 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.7497  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma, Clear Cell--metabolism<br/>Autophagy<br/>Biomarkers, Tumor--metabolism<br/>Cardiac Glycosides--pharmacology<br/>Cell Death<br/>Cell Line, Tumor<br/>Female<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Enzymologic<br/>Gene Expression Regulation, Neoplastic<br/>Gene Silencing<br/>Humans<br/>Ovarian Neoplasms--metabolism<br/>Prognosis<br/>Sodium-Potassium-Exchanging ATPase--metabolism<br/>Up-Regulation